(Date:11/23/2009)...v.,Nov.23/PRNewswire-FirstCall/--PDLBioPharma,Inc....ablishedNovember27,2009astheex-dividenddateforits$...omthesecuritizationtransactioncompletedonNovember2...tockholdersofrecordontherecorddate,December1,2009....endat$1.67pershareofcommonstockforpurposesoftheex-...
(Date:11/23/2009)....23/PRNewswire-FirstCall/--NeogenCorporation(Nasda...waselectedtoNeogen,sBoardofDirectorsatthecompany,s...smorethan40yearsofexperienceinthefood,agriculture,...fessorofagriculturaleconomicsatVirginiaTechUnivers...ateschiefagriculturenegotiatorwiththerankofambassa...
(Date:11/23/2009)...Newswire/--ImmuneDesignC or p.(IDC)announcedtodayt...an.Dr.Carterhasasuccessfultrackrec or dinbiotechno...tiveOfficeratZymoGenetics,inSeattle,WAandChiefScie..., (Photo: http://www.newscom.com/cgi-bin/prnh/2...andChiefExecutiveOfficercommented,"Iamdelightedtow...
(Date:11/23/2009)...f.,Nov.23/PRNewswire/--Frost&Sullivan,theGrowt...emonstratingleadershipandinnovationThursday,Novemb...dsBanquetheldinSanAntonio,Texas. ,, (Logo: http...,, TheHealthcareInnovationAwardsaregiventocompa...eryandmanagementofhealthcare.Suchcompanieshaveshow...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3...genetic anticancer program at Pharmion - L... - Sirtuins implicated in tumor developmen...re combination epigenetic therapies, BOULDER, Col...sdaq: PHRM ) and MethylGene Inc. (TSX: MYG) today...pment of novel small molecule,inhibitors targeting...
... CLAREMONT, Calif., Aug. 14 /Xinhua-PRNewswire-Fir...n (OTC Bulletin Board: KWBT),announced that revenu...han,35% over the first quarter of 2007 exceeding $...351 for the same period in the previous year. Rev...ompared to only,$24,374 in the first half of 2006....
...d., Aug. 14 Martek Biosciences,Corporation announ...third,quarter of fiscal 2007 on September 5, 2007,...(EDT). Following the release, at 4:45 p.m. EDT Mar...ults of its third quarter of,fiscal 2007 with inve...e,hour in duration. The conference call will also ...
Other Biology Technology:Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 2Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 3Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 4Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 5Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 6Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 2Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 3Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 4Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 5Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 6Martek to Announce Third Quarter 2007 Results on September 5, 2007 2...s of cancer continues to pose a major problem for ... forms of chemotherapy or become resistant to the ... Infection Research (HZI) in Braunschweig, the Han...(LUH) in Hanover have now discovered a chemical me... destroys tumours. Today, the researchers publish ...
...of on-the-go crop and soil sensors has greatly inc... their crops. Recently released research in Agron...ment is necessarily more efficient. They discovere...recision agriculture, calculating how large of an ...nt techniques. According to the authors, this chan...
...h . , Barcelona, Spain: Couples who need IVF i...his will not lead to developmental problems in ear...l conference of the European Society of Human Repr.... Karin Middelburg, from the University Medical Ce...hat the study, which looked at the quality of gene...
Other Biology News:Argyrin: Natural substance raises hope for new cancer therapies 2IVF does not increase risk of developmental disorders in children 2Mouse Anti-Human Non-SMC condensin II complex, subunit D3 (NCAPD3) Monoclonal Antibody, Unconjugated from Lifespan Biosciences
TSQ Quantum Discovery MAX from Thermo Scientific
Flp-In T-REx Core Kit from Invitrogen
BD Falcon 1536-well Black Microplates from BD Biosciences - Discovery Labware
Biology Products: